FrieslandCampina Research and Development
Wageningen, 6708 WH, Netherlands
NCT Number: NCT06251427
A new product was developed by FrieslandCampina for Sub-Saharan Africa as affordable nutrition to nourish Nigerian families of low to middle-socioeconomic class (SEC). It can potentially be used to enhance the ongoing school feeding programs, which are aimed at reducing malnutrition, including micronutrient deficiencies. The main component of the product is maize, which is a traditional staple in Nigeria. The product also contains milk (being a good source of high quality protein) fortified with various micronutrients including iron, iodine, zinc, vitamin A and vitamin B12 at levels contributing to approximately 1/3 of daily recommended intakes per serving of product. Intake of this product may therefore contribute to improvement of micronutrient status among Nigerian schoolchildren suffering from such nutrient deficiencies. Micronutrients are important for various processes in the body, which in turn may influence other outcomes as cognitive performance, reduce illness and improve growth.
Looking for future studies?
Notify Me5 year–8 year
All sexes
Interventional
Not applicable
Wageningen, 6708 WH, Netherlands
The study is a double-blinded three-arm intervention trial. The individual children will be randomised into the three different arms of the study, with varying doses of micronutrients (1) low, (2) medium and (3) high.
The 50g of study product will be given to school children every school day (5/7 days of the week) for 5 intervention months.
Study product: A fermented maize pap, with soy, dairy and multiple micronutrient fortification. Active components: Multiple micronutrient fortification, including ferrous fumarate. Amount of micronutrients differ based on the arm of the study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study product is a multiple micronutrient fortified maize pap with milk
Time frame: 5 months
There will be a change between the two test groups and the control group in iron status as measured by in hemoglobin (whole blood) g/L .
Time frame: 5 months
There will be a change between the two test groups and the control group in iron status as measured by serum ferritin (ug/L).
Time frame: 5 months
There will be a difference in prevalence of iron-deficiency, iron-deficiency anaemia and anaemia, taking modifying factors like soluble transferrin receptor and inflammation markers in plasma into account.
Time frame: 5 months
A difference in nutrient status of selected nutrients (iodine, vitamin A, zinc, vitamin B12, vitamin D)
Time frame: 5 months
A difference in cognitive performance score, measured via attention (Digit span backward) and short-term memory (digit-span forward) score (higher scores indicate a better outcome.
Time frame: 5 months
Difference in anthropometric status between study arms as measured by height-for-age Z score (HAZ) and weight-for-age (WAZ).
Time frame: 5 months
Difference in morbidity/illness as measured by the reduced frequency of illness over the 5 months
FrieslandCampina
Industry
Assessing the Effectiveness of a Multiple-micronutrient Fortified Maize Pap on the Nutrient Status of Nigerian School-aged Children: Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07186205
Anemia, Hematologic Diseases
Abidjan, Côte d’Ivoire
View Trial DetailsNCT06238895
Anemia, Anemia, Hypochromic
Lucerne, Switzerland
View Trial DetailsNCT06309641
Anemia, Hematologic Diseases
Falun, Sweden
View Trial DetailsNCT06032832
Iron Deficiencies, Iron Metabolism Disorders
Zurich, Canton of Zurich, Switzerland
View Trial Details